Teleflex Inc
TFX- Exchange
- NYSE
- Industry
- Surgical & Medical Instruments & Apparatus
- SEC CIK
- 0000096943
No open-market purchases or sales by Teleflex Inc insiders were filed in the last 90 days; 385 institutions reported holding it in 13F filings for Q2 2026, worth $6.08B in total; Baupost Group is the only superinvestor holding it.
- Currency
- USD
- Source
- SEC XBRL data (10-K, 10-Q, 20-F, 40-F)
- Updated
- Nov 8, 2026, 10:29 PM ET
Revenue flow, FY2025
Where the revenue went in FY2025, from the income statement below. Green is profit; orange is costs, expenses and taxes. Percentages are shares of revenue; hover over a band or a bar for the exact amount.
Net loss for FY2025: $905.6M (45.4% of revenue).
Income statement
Each column is one fiscal year, newest first.
| Line item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Period end | Dec 31, 2025 | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 |
| Filing | 10-K | 10-K | 10-K | 10-K | 10-K |
| Reported | Jan 8, 2026 | Feb 27, 2025 | Feb 22, 2024 | Feb 23, 2023 | Feb 24, 2022 |
| Revenue | $1.99B | $3.05B | $2.97B | $2.79B | $2.81B |
| Cost of revenue | $872.0M | $1.34B | $1.33B | $1.26B | $1.26B |
| Gross profit | $1.12B | $1.70B | $1.65B | $1.53B | $1.55B |
| Research and development | $144.8M | $161.7M | $154.4M | $153.8M | $130.8M |
| Selling, general and administrative | $720.2M | $995.3M | $929.9M | $863.7M | $860.1M |
| Operating income | $118.4M | $151.0M | $506.3M | $499.7M | $628.1M |
| Interest expense | – | – | $85.1M | $54.3M | $57.0M |
| Income tax | -$34.0M | $5.32M | $76.4M | $83.0M | $74.3M |
| Net income | -$905.6M | $69.7M | $356.3M | $363.1M | $485.4M |
| EPS, basic | $-20.30 | $1.49 | $7.58 | $7.74 | $10.38 |
| EPS, diluted | $-20.25 | $1.48 | $7.53 | $7.68 | $10.23 |
| Weighted shares, basic | 44.6M | 46.8M | 47.0M | 46.9M | 46.8M |
| Weighted shares, diluted | 44.7M | 47.1M | 47.3M | 47.3M | 47.4M |
| Margins and growth | |||||
| Gross margin | 56.2% | 55.9% | 55.4% | 54.9% | 55.2% |
| Operating margin | 5.9% | 5.0% | 17.0% | 17.9% | 22.4% |
| Net margin | -45.4% | 2.3% | 12.0% | 13.0% | 17.3% |
| Revenue growth, year over year | −34.6% | +2.4% | +6.6% | −0.7% | +10.7% |
| Net income growth, year over year | −1,399.8% | −80.4% | −1.9% | −25.2% | +44.7% |
Balance sheet
Each column is one fiscal year, newest first.
| Line item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Period end | Dec 31, 2025 | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 |
| Filing | 10-K | 10-K | 10-K | 10-K | 10-K |
| Reported | Jan 8, 2026 | Feb 27, 2025 | Feb 22, 2024 | Feb 23, 2023 | Feb 24, 2022 |
| Cash and equivalents | $378.6M | $290.2M | $222.8M | $292.0M | $445.1M |
| Accounts receivable | $345.6M | $459.5M | $443.5M | $408.8M | $383.6M |
| Inventory | $404.4M | $600.1M | $626.2M | $578.5M | $477.6M |
| Total current assets | $1.94B | $1.47B | $1.41B | $1.41B | $1.43B |
| Property, plant and equipment | $498.3M | $502.9M | $479.9M | $447.2M | $443.8M |
| Goodwill | $2.31B | $2.63B | $2.91B | $2.54B | $2.50B |
| Intangible assets | $1.52B | $2.27B | $2.50B | $2.31B | $2.29B |
| Total assets | $6.95B | $7.10B | $7.53B | $6.93B | $6.87B |
| Accounts payable | $130.2M | $141.0M | $132.2M | $126.8M | $118.2M |
| Short-term debt | $100.0M | $100.0M | $87.5M | $87.5M | $110.0M |
| Total current liabilities | $762.0M | $649.4M | $606.7M | $581.5M | $680.1M |
| Long-term debt | $2.54B | $1.56B | $1.73B | $1.62B | $1.74B |
| Total liabilities | $3.82B | $2.82B | $3.09B | $2.91B | $3.12B |
| Shareholders' equity | $3.12B | $4.28B | $4.44B | $4.02B | $3.75B |
Cash flow statement
Each column is one fiscal year, newest first. Free cash flow is operating cash flow minus capital expenditures.
| Line item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Period end | Dec 31, 2025 | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 |
| Filing | 10-K | 10-K | 10-K | 10-K | 10-K |
| Reported | Jan 8, 2026 | Feb 27, 2025 | Feb 22, 2024 | Feb 23, 2023 | Feb 24, 2022 |
| Capital expenditures | $95.2M | $126.4M | $91.4M | $79.2M | $71.6M |
| Depreciation and amortization | $177.7M | $274.6M | $242.1M | $230.6M | $237.4M |
| Stock-based compensation | $25.7M | $31.3M | $31.5M | $27.2M | $22.9M |
| Dividends paid | $60.3M | $63.5M | $63.9M | $63.8M | $63.6M |
| Share buybacks | $300.0M | $200.0M | – | – | – |
| Investing cash flow | – | – | – | – | $156.7M |
| Financing cash flow | $611.5M | -$421.9M | $38.5M | -$217.5M | -$715.8M |
| Net change in cash | $126.2M | $104.8M | -$69.2M | -$153.1M | $69.2M |
| Ratio | |||||
| Stock-based compensation, % of revenue | 1.3% | 1.0% | 1.1% | 1.0% | 0.8% |
Shares outstanding
Common shares outstanding as stated on the cover of each 10-K and 10-Q. The date is the cover date, not the period end; a rising count means dilution.
Notes and known gaps
How these numbers are put together, and what they can't tell you.
- Numbers come from the XBRL data in each period's original 10-K, 10-Q, 20-F or 40-F, or its amendment. They are shown as filed: later filings don't restate earlier periods here.
- Reported is the filing date of the first 8-K with Item 2.02 (results of operations) after the period ended, no later than the 10-Q or 10-K and within 120 days. Companies that release results only in the 10-Q, and foreign companies, which use Form 6-K, have none.
Known gaps
- Foreign companies that file Form 20-F or 40-F have annual statements only: their quarterly results are furnished on Form 6-K, which has no XBRL data.
- EPS and share counts are as reported at the time, not adjusted for later stock splits.
- For ADRs, EPS is per ordinary share, not per ADS (one TSMC ADS is five ordinary shares).
- For banks, revenue may be interest income only, depending on how the bank tags its filings; cost of revenue and gross profit are usually blank.
- Companies with several share classes, such as Berkshire Hathaway, may have no EPS and no cover share count.
- Depreciation and amortization is missing for some companies that report it under their own XBRL tags.